CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.575

Change

-0.04 (-0.68)%

Market Cap

USD 0.61B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.93%)

USD 65.72B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-3.60 (-0.74%)

USD 10.57B
WRD:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.30%)

USD 9.08B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.66 (+0.70%)

USD 7.63B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-4.95 (-1.16%)

USD 6.82B
HHH:PA HSBC ETFs Public Limited Compa..

-0.36 (-0.74%)

USD 6.67B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.01 (-0.32%)

USD 6.34B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.38%)

USD 5.17B
500U:PA Amundi Index Solutions - Amund..

-0.37 (-0.36%)

USD 4.71B
WSRI:PA Amundi MSCI World SRI Climate ..

-0.15 (-0.16%)

USD 3.99B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.25% 64% D 68% D+
Dividend Return N/A 7% C- 12% F
Total Return N/A 66% D+ 24% F
Trailing 12 Months  
Capital Gain -4.04% 10% F 36% F
Dividend Return N/A 51% F 48% F
Total Return N/A 49% F 60% D-
Trailing 5 Years  
Capital Gain -20.70% 7% C- 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.70% 6% D- 22% F
Average Annual (5 Year Horizon)  
Capital Gain 1.62% 35% F 41% F
Dividend Return N/A 13% F 30% F
Total Return N/A 22% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 34% F 5% F
Risk Adjusted Return N/A 44% F 2% F
Market Capitalization 0.61B 75% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.